Detalhe da pesquisa
1.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
2.
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
Blood
; 132(21): 2273-2279, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30166329
3.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
4.
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol
; 18(4): 454-463, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236583
5.
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Lancet Oncol
; 18(12): 1680-1687, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133014
6.
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 125(26): 4024-31, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887777
7.
Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.
Eur J Nucl Med Mol Imaging
; 43(2): 249-258, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26280981
8.
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Leukemia
; 38(1): 160-167, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845285
9.
Erratum to: Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.
Eur J Nucl Med Mol Imaging
; 43(1): 204-205, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481912
10.
Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?
Nucl Med Commun
; 40(3): 249-257, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30461699
11.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
J Clin Oncol
; 37(31): 2835-2845, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31498753
12.
Metabolic Tumour Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.
J Nucl Med
; 2018 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880508
13.
In vivo Patterns of Tau Pathology, Amyloid-ß Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
J Alzheimers Dis
; 55(2): 465-471, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802224
14.
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
Mol Imaging Biol
; 17(4): 575-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26013479
15.
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Int J Radiat Oncol Biol Phys
; 92(1): 46-53, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25863753
16.
18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Leuk Lymphoma
; 55(4): 811-6, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23805904
17.
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
J Clin Oncol
; 32(17): 1776-81, 2014 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24799482
18.
Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma.
Leuk Lymphoma
; 54(10): 2144-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23402268
19.
Developments in oncological positron emission tomography/computed tomography assessment.
J Thorac Dis
; 7(12): E637-9, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26793379